Skip to main content

Advertisement

SpringerLink
Log in

Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors

Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Background Leptomeningeal metastasis (LM) occurs in 4–15% of patients with solid tumors. Although the clinical outcomes in cancer patients have been improving recently, no standard treatment for LM has been established as yet. The purpose of this study was to identify the prognostic factors in patients with solid tumors with cytologically proven LM. Methods We retrospectively analyzed a series of 85 consecutive patients with cytologically proven LM who were treated between 1997 and 2005. Results The primary diseases were as follows; lung cancer (n = 36), breast cancer (n = 33), gastric cancer (n = 8), and others (n = 8). Forty-nine patients had brain metastasis at the time of diagnosis of the LM, and in 51 patients, MRI revealed meningeal dissemination in the brain or spine. The performance status (PS) was 0–1 in 26 patients and 2–4 in 59 patients. Thirty-one patients, including 19 with breast cancer, four with lung cancer, five with gastric cancer and three with other cancers, were treated by intrathecal (IT) chemotherapy. The response rate to the IT was 52% (95% confidence interval (CI): 41.4–62.6%). The median survival was 51 days (range, 3–759 days). A univariate analysis identified breast cancer, good PS (0–1), time to development of the LM (>1 year), and treatment by IT chemotherapy as being associated with a good prognosis, and multivariate analysis identified poor PS (HR: 1.72 (95% CI, 1.04–2.86) P = 0.04) and MRI-proven LM (HR: 1.82 (95% CI, 1.11–2.98) P = 0.02) as being associated with a poor prognosis. Conclusion In patients with poor prognostic factors, such as poor PS or MRI-proven LM, palliative therapy might be the most suitable treatment strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Chamberlain MC (1998) Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 37:271–284. doi:10.1023/A:1005976926058

    Article  PubMed  CAS  Google Scholar 

  2. Jayson GC, Howell A (1996) Carcinomatous meningitis in solid tumors. Ann Oncol 7:773–786

    PubMed  CAS  Google Scholar 

  3. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103–109. doi:10.1053/ctrv.1999.0119

    Article  PubMed  CAS  Google Scholar 

  4. Glass JP, Melamed M, Chernik NL et al (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369–1375

    PubMed  CAS  Google Scholar 

  5. Wasserstorm WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759–772. doi:10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7

    Article  Google Scholar 

  6. Singh SK, Agris JM, Leeds NE et al (2000) Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging. Radiology 217:50–53

    PubMed  CAS  Google Scholar 

  7. Yousem DM, Patrone PM, Grossman RI (1990) Leptomeningeal metastases: MR evaluation. J Comput Assist Tomogr 14:255–261. doi:10.1097/00004728-199003000-00018

    Article  PubMed  CAS  Google Scholar 

  8. Rodesch G, Van Bogaert P, Mavroudakis N et al (1990) Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI. Neuroradiology 32:26–32. doi:10.1007/BF00593937

    Article  PubMed  CAS  Google Scholar 

  9. Lee JL, Kang YK, Kim TW et al (2004) Leptomeningeal carcinomatosis in gastric cancer. J Neurooncol 66:167–174. doi:10.1023/B:NEON.0000013462.43156.f4

    Article  PubMed  Google Scholar 

  10. Seute T, Leffers P, ten Velde GP et al (2005) Leptomeningeal metastases from small cell lung carcinoma. Cancer 104:1700–1705. doi:10.1002/cncr.21322

    Article  PubMed  Google Scholar 

  11. Giglio P, Weinberg JS, Forman AD et al (2005) Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer 103:2355–2362. doi:10.1002/cncr.21082

    Article  PubMed  Google Scholar 

  12. Jayson GC, Howell A, Harris M et al (1994) Carcinomatous meningitis in patients with breast cancer. Cancer 74:3135–3141. doi:10.1002/1097-0142(19941215)74:12<3135::AID-CNCR2820741212>3.0.CO;2-8

    Article  PubMed  CAS  Google Scholar 

  13. Boogerd W, Hart AA, van der Sande JJ et al (1991) Meningeal carcinomatosis in breast cancer. Cancer 67:1685–1695. doi:10.1002/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M

    Article  PubMed  CAS  Google Scholar 

  14. Fizazi K, Asselain B, Vincent-Salomon A et al (1996) Meningeal carcinomatosis in patients with breast carcinoma. Cancer 77:1315–1323. doi:10.1002/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4

    Article  PubMed  CAS  Google Scholar 

  15. Orlando L, Curigliano G, Colleoni M et al (2002) Intrathecal chemotherapy in carcinomatous meningitis from breast cancer. Anticancer Res 22:3057–3060

    PubMed  Google Scholar 

  16. Hitchins RN, Bell DR, Woods RL et al (1987) A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5:1655–1662

    PubMed  CAS  Google Scholar 

  17. Chamberlain MC, Kormanik PRN (1997) Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy. J Neurooncol 35:55–64. doi:10.1023/A:1005803918194

    Article  PubMed  CAS  Google Scholar 

  18. Suki D, Abouassi H, Patel AJ et al (2008) Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 108:248–257. doi:10.3171/JNS/2008/108/2/0248

    Article  PubMed  Google Scholar 

  19. Grossman SA, Finkelstein DM, Ruckdeschel JC et al (1993) Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern cooperative oncology group. J Clin Oncol 11:561–569

    PubMed  CAS  Google Scholar 

  20. Freilich RJ, Krol G, DeAngelis LM (1995) Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38:51–57. doi:10.1002/ana.410380111

    Article  PubMed  CAS  Google Scholar 

  21. Posner JB (1995) Neurologic complications of cancer. F.A. Davis Company, Philadelphia

    Google Scholar 

  22. Murray JJ, Greco FA, Wolff SN et al (1983) Neoplastic meningitis marked variations of cerebrospinal fluid composition in the absence of extradural block. Am J Med 75:239–294. doi:10.1016/0002-9343(83)91207-X

    Article  Google Scholar 

  23. Boogerd W, van den Bent MJ, Koehler PJ et al (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomized study. Eur J Cancer 40:2726–2733. doi:10.1016/j.ejca.2004.08.012

    Article  PubMed  CAS  Google Scholar 

  24. NCCN Clinical Practice Guideline in Oncology (2007) Central nervous system cancers, carcinomatous/lymphomatous meningitis (CLMEN-1). Version 1:21–24

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Fusako Waki, Masashi Ando, Kan Yonemori & Yasuhiro Fujiwara

  2. Faculty of Medicine, Division of Hematology, Department of Internal Medicine, Kagawa University, Takamatsu, Japan

    Fusako Waki

  3. Thoracic Oncology Division, National Cancer Center Hospital, Tokyo, Japan

    Atsuo Takashima, Hiroshi Nokihara & Tomohide Tamura

  4. Diagnostic Radiology Division, National Cancer Center Hospital, Tokyo, Japan

    Mototaka Miyake & Ukihide Tateishi

  5. Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan

    Koji Tsuta

  6. Gastrointestinal Division, National Cancer Center Hospital, Tokyo, Japan

    Yasuhiro Shimada

Authors
  1. Fusako Waki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masashi Ando
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atsuo Takashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kan Yonemori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Nokihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mototaka Miyake
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ukihide Tateishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Koji Tsuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yasuhiro Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yasuhiro Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tomohide Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fusako Waki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waki, F., Ando, M., Takashima, A. et al. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93, 205–212 (2009). https://doi.org/10.1007/s11060-008-9758-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-008-9758-3

Keywords

Search

Navigation